PMID: 9642602Jun 27, 1998Paper

Delayed-onset Pseudomonas stutzeri endophthalmitis after uncomplicated cataract surgery

Journal of Cataract and Refractive Surgery
N Jirásková, P Rozsíval

Abstract

An 88-year-old woman had uneventful extracapsular cataract extraction with posterior chamber intraocular lens (IOL) implantation in her right eye. Seven weeks later, an anterior vitrectomy with removal of the IOL was performed because of endophthalmitis resistant to topical and systemic amoxicillin, cephalosporin, aminoglycoside, and steroids. Microbiological examination of the vitreous biopsy, capsule, and anterior chamber fluid disclosed Pseudomonas stutzeri, gram-negative nonfermentative bacteria sensitive to tetracycline, ceftazidime, gentamicin, ofloxacin, and piperacillin. Pseudomonas stutzeri should be considered in the treatment of delayed-onset endophthalmitis.

References

May 1, 1986·The Journal of Applied Bacteriology·B Holmes
Mar 1, 1996·American Journal of Ophthalmology·W A Townsend-PicoJ A Costin
Aug 1, 1996·American Journal of Ophthalmology·M BraunG O Naumann

❮ Previous
Next ❯

Citations

Mar 12, 2004·American Journal of Ophthalmology·Chong Fai Chung, Dennis S C Lam
Jul 31, 2003·American Journal of Ophthalmology·Blake A CooperPaul A Thompson
May 31, 2002·Journal of Cataract and Refractive Surgery·Per G MontanCharlotta Zetterström
Jan 29, 2003·Journal of Cataract and Refractive Surgery·Yasunori NagakiTomohiro Abe
Jun 9, 2006·Microbiology and Molecular Biology Reviews : MMBR·Jorge LalucatNorberto J Palleroni
Jun 28, 2013·Indian Journal of Ophthalmology·Kalpana Badami Nagaraj, Chaitra Jayadev
Sep 25, 2008·Journal of Cataract and Refractive Surgery·Takashi SuzukiYuichi Ohashi
Nov 9, 2005·The Journal of Infection·Angela LoyseMark Melzer
Jun 7, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Alexis ElwardVictoria Fraser
Nov 4, 2006·International Journal of Systematic and Evolutionary Microbiology·Ana I VelaJosé F Fernández-Garayzábal
Apr 2, 2019·Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society·Zeynep Eylül ErcanGürsel Yılmaz
Dec 21, 2019·Indian Journal of Ophthalmology·Ankit ShahRupak Roy
Jun 7, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Stephanie Yee-GuardinoJohanna Goldfarb
Jul 18, 2001·European Journal of Ophthalmology·J M Ruiz-MorenoF de la Hoz
Jan 14, 2021·Case Reports in Ophthalmology·Saeed T Alshahrani, J Fernando Arevalo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

The British Journal of Ophthalmology
J W BainbridgeC K Rostron
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
M I Campos-HerreroA Conde
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
P RoigV Navarro
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
R B Reisler, H Blumberg
© 2022 Meta ULC. All rights reserved